{"slug":"thymosin-alpha-1-chemo-neuropathy","verification":{"valid":true,"entries":2,"head":"226bf0a5f894867291d026fa4d762d51d646c05176b8b14f9c6a353c928dca98"},"energy":{"passes":2,"tokens_in":35400,"tokens_out":3597,"tokens_total":38997,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"226bf0a5f894867291d026fa4d762d51d646c05176b8b14f9c6a353c928dca98"},"provenance":[{"ts":"2026-06-29T23:08:03.874Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Thymosin Alpha 1 for Chemo Neuropathy\nSlug: thymosin-alpha-1-chemo-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Chemotherapy-induced neuropathy (CIPN)\",\"condition_key\":\"chemo-neuropathy\",\"primary_peptide\":\"thymosin-alpha-1\",\"peptides_in_scope\":[{\"id\":\"thymosin-alpha-1\",\"name\":\"Thymosin Alpha-1\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"thymosin-alpha-1\",\"name\":\"Thymosin Alpha-1\",\"section_title\":\"Why Thymosin Alpha-1 might help you\",\"layer\":\"immune modulation\",\"steps\":[\"You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"gabapentin-lyrica\",\"name\":\"Gabapentin / pregabalin\",\"section_title\":\"Why Gabapentin / pregabalin matters for you\",\"steps\":[\"**Drug:** Gabap","response":"```json\n{\n  \"slug\": \"thymosin-alpha-1-chemo-neuropathy\",\n  \"title\": \"Thymosin Alpha 1 for Chemotherapy-Induced Neuropathy: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\\n\\nChemotherapy-induced peripheral neuropathy (CIPN) involves damage to sensory nerves in the hands and feet, often in a stocking-glove pattern. Symptoms include numbness, tingling, burning pain, and loss of sensation or balance. Certain chemotherapies like taxanes, platinums, and vinca alkaloids trigger this through direct axonal injury, mitochondrial dysfunction, and inflammatory responses in immune cells.\\n\\nRecent work points to immune cells, particularly myeloid cells in circulation and dorsal root ganglia, as key drivers via stress pathways like IRE1α activation rather than neuron damage alone. This creates ongoing neuroinflammation that sustains symptoms even after treatment ends. Repair pathways for myelin and axons lag behind the breakdown, allowing persistence.\\n\\nIf immune modulation or reduced inflammation is part of your picture, compounds targeting those layers get discussed for potential repair support rather than symptom masking.\\n\\n## Why Thymosin Alpha-1 might help you\\n\\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nThymosin Alpha-1 acts primarily through immune modulation. It promotes T-cell maturation and function, enhances natural killer cell activity, and shifts cytokine profiles. In the context of CIPN, where immune cell-driven inflammation contributes, this could support resolution of that inflammatory component. If your neuropathy involves persistent low-grade immune activation post-chemo, the peptide's effects on T-cell balance and reduced pro-inflammatory signaling represent a poten","tokens_in":35400,"tokens_out":3597,"cost":0,"prev":"genesis","hash":"607abd2e9b8828ba3a6a9bc073ba21adce29c6df7b7c88dc11e4d19562ba03c1"},{"ts":"2026-07-17T02:43:04.907Z","model":"owner","action":"voxel_divide","prompt":"","input":"thymosin-alpha-1-chemo-neuropathy","response":"29 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"607abd2e9b8828ba3a6a9bc073ba21adce29c6df7b7c88dc11e4d19562ba03c1","hash":"226bf0a5f894867291d026fa4d762d51d646c05176b8b14f9c6a353c928dca98"}]}